Ngā hua rapu - Dave Singh

Whakamahine hua
  1. 1
    New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives

    New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives mā Dave Singh

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease

    Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease mā Dave Singh

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Pharmacological treatment of stable chronic obstructive pulmonary disease

    Pharmacological treatment of stable chronic obstructive pulmonary disease mā Dave Singh

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight

    Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight mā Andrew Higham, Dave Singh

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription

    The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription mā Christian Domingo, Dave Singh

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Exhaled breath condensate biomarkers in COPD

    Exhaled breath condensate biomarkers in COPD mā Zöe Borrill, Kay Roy, Dave Singh

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    CRTH2 antagonists in asthma: current perspectives

    CRTH2 antagonists in asthma: current perspectives mā Dave Singh, Arjun Ravi, Thomas Southworth

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages

    Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages mā Jane Armstrong, Carol A. Sargent, Dave Singh

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

    Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective mā David Halpin, Dave Singh, Ruth M. Hadfield

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Chronic obstructive pulmonary disease and COVID-19: interrelationships

    Chronic obstructive pulmonary disease and COVID-19: interrelationships mā Dave Singh, Alexander G. Mathioudakis, Andrew Higham

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

    Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial mā Kai Michael Beeh, Dave Singh, Di Scala, Drollmann

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    How inhaled corticosteroids target inflammation in COPD

    How inhaled corticosteroids target inflammation in COPD mā Simon Lea, Andrew Higham, Augusta Beech, Dave Singh

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study

    Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study mā Dave Singh, Lisa Edwards, Ruth Tal‐Singer, Stephen Rennard

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review

    Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review mā Marc Miravitlles, Anthony D’Urzo, Dave Singh, Vladimir Koblížek

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    COVID-19 and COPD: a narrative review of the basic science and clinical outcomes

    COVID-19 and COPD: a narrative review of the basic science and clinical outcomes mā Andrew Higham, Alexander G. Mathioudakis, Jørgen Vestbo, Dave Singh

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs

    Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs mā Kate Gaffey, Sophie Reynolds, Jonathan Plumb, Manminder Kaur, Dave Singh

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses

    The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses mā Andrew Higham, Declan Bostock, George Booth, Josiah Dungwa, Dave Singh

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The reproducibility of COPD blood eosinophil counts

    The reproducibility of COPD blood eosinophil counts mā Thomas Southworth, Gussie Beech, Philip Foden, Umme Kolsum, Dave Singh

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD

    The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD mā Dave Singh, Katharine Abbott-Banner, Thomas Bengtsson, Ken B. Newman

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation

    Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation mā Robert A. Stockley, David Halpin, Bartolomé R. Celli, Dave Singh

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: